Vanderbilt Ingram Cancer Center

October 29, 2020

Lovly to chair foundation’s scientific leadership board

Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).

October 29, 2020

VUMC researchers selected for inaugural FDA-AACR fellowship

Henry Henderson III, PhD, and Justin Lo, MD, PhD, are members of the 2020-2021 inaugural class of FDA-AACR Oncology Educational Fellows.

October 29, 2020

New markers of colorectal cancer risk

Vanderbilt epidemiologists identified new markers for colorectal cancer risk and characterized a previously unidentified tumor suppressor that regulates overall tumor volume in vivo.

October 21, 2020

Park named director of Hematology and Oncology at VICC

After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, Donna S. Hall Professor of Breast Cancer Research at Vanderbilt University Medical Center, has been named director of the Division of Hematology and Oncology.

October 15, 2020

Noninvasive treatment for refractory OCD, major depression shows promise for lifelong benefits

Four months ago, a multidisciplinary care team at Vanderbilt University Medical Center treated a patient with lifelong major depressive disorder (MDD) and obsessive compulsive disorder (OCD) — conditions that left her debilitated with intrusive thoughts, constant fear, suicidal intent and anorexia.

October 9, 2020

Erlanger Health System and Vanderbilt-Ingram Cancer Center partner in cancer care

Erlanger Health System and Vanderbilt University Medical Center, on behalf of Vanderbilt-Ingram Cancer Center (VICC), have entered into a professional service agreement designing a long-term collaboration in comprehensive cancer care, including VICC hematology-oncology services at Erlanger Oncology and Hematology and infusion locations.